Dow to add alkoxylation capacity
Dow has announced plans to expand its alkoxylation capacity in the US and Europe in 2024 and 2025. The investments are backed by supply agreements with customers and are being made to meet 10-15%/year growth in end markets including home and personal care, industrial and institutional cleaning, pharmaceuticals and crop protection.
Precise volumes were not disclosed but the company said that, combined with expansions announced in Louisiana and Spain in 2019 that are due to come onstream this year, these project will add up to a 70% increase in capacity on 2020. Together with other efficiency projects this is expected to generate more than $150 million in run-rate EBITDA by 2025.
RELATED ARTICLES
AlzChem plans to “significantly increase” its nitroguanidine capacity, with a new production plant that will almost double the €76 million expansion it announced in the spring.
Karsten Smet, CEO of ACI Group, looks at ways the pharmaceutical and agrochemical industries can adapt to changing times
BASF is to end production of three chemicals at its main site in Ludwigshafen. This is part of an ongoing strategic review that is being undertaken “to ensure competitiveness under changing market conditions” and will lead to about 180 job cuts.
Barentz International has acquired distributors in two different regions in short order. The acquisition of Insuqui in Paraguay followed a few weeks after that of the Anshul Life Sciences Group in India.
Price pressure stalls re-shoring in US agrochemicals, but business was brisk with positive energy at the Specialty & Agro Chemicals America event. Gregory D.L. Morris reports from Savannah
FMC Corporation has agreed to sell its Global Specialty Solutions (GSS) business to Envu for $350 million, subject to closing working capital adjustment. The deal is expected to close by year-end 2024, subject to regulatory approval and other customary closing conditions.
